Galectin Therapeutics GALT
NASDAQ GALT
$4.61 +0.26 (+5.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026)

Galectin Therapeutics (GALT) posted quarterly Prepaid Assets of $1.6 million for Q1 2026, down 14.78% year-over-year from $1.9 million in Q1 2025, and down 7.93% quarter-over-quarter from $1.7 million in Q4 2025.

Analysis

Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026) Analysis & Trends

Galectin Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • In Q1 2026, Prepaid Assets fell 14.78% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 14.78% YoY), while the FY2025 annual figure was $1.7 million, down 19.51% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $1.6 million, down from $1.7 million in the prior quarter.
  • The five-year high for Prepaid Assets was $2.1 million in Q4 2024, with the low at $1.2 million in Q3 2025.
  • The 5-year median for Prepaid Assets is $1.7 million (2024), against an average of $1.7 million.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets gained 28.58% in 2024, then slipped 25.03% in 2025.
  • Galectin Therapeutics' Prepaid Assets stood at $2.0 million in 2022, then climbed by 4.59% to $2.0 million in 2023, then advanced by 4.0% to $2.1 million in 2024, then fell by 19.51% to $1.7 million in 2025, then slipped by 7.93% to $1.6 million in 2026.
  • Business Quant data shows GALT's Prepaid Assets at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Galectin Therapeutics 304.34 Mn 304.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Mn
Mar 31, 2026 1.58 Mn
Dec 31, 2025 1.72 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 2.13 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.75 Mn
Dec 31, 2022 1.96 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.61 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 2.17 Mn
Sep 30, 2021 1.40 Mn